US · Healthcare · Medical Devices
EPS came in at -0.22 against a street estimate of -0.00 — a miss of 6013.9%.
Analysts rate Alphatec Holdings Inc a buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $15.86.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.56% |
| American Century Companies Inc | 4.18% |
| Vanguard Capital Management, LLC | 3.20% |
| Royal Bank of Canada | 2.94% |
| BNP Paribas Investment Partners SA | 2.35% |
| State Street Corp | 1.97% |
| Geode Capital Management, LLC | 1.89% |
| Nuveen, LLC | 1.85% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-06-11 |
| Quarterly report · Q1 2026 | 2026-05-05 |
| Results announced · Q2 2026 | 2026-05-05 |
| Proxy statement · Q2 2026 | 2026-04-29 |
| Board / officer change · Q1 2026 | 2026-03-03 |
| Annual report FY2025 | 2026-02-24 |
| Results announced · Q1 2026 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-10-30 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alphatec Holdings Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.